Brijesh H Kadam, MD
Pediatric Medicine · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Bay Area Community Health · 106 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kadam’s office at (408) 729-9700 to ask if they take your plan before you enroll.
California Medical Board record
Licence A109208 · Current
Licensed to practise in California · since 2009 · expires 2026-11-30 · University of Pune, B. J. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$550,075 in 2024
Medicaid paid $550,075 for 6,507 billed services this clinician did in 2024, up to 317 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 3,402 | $539,351 |
| 1ST HOSP IP/OBS HIGH 75 | 45 | $7,794 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 29 | $2,371 |
| Service | 13 | $559 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 888 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 574 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 192 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 254 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 78 | $0 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 53 | $0 |
| Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use | 52 | $0 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 231 | $0 |
| 2024 | 6,507 | 20 | 317 | $550,075 |
| 2023 | 6,475 | 16 | 342 | $504,203 |
| 2022 | 3,201 | 15 | 237 | $272,652 |
| 2021 | 4,773 | 10 | 239 | $335,016 |
| 2020 | 4,047 | 13 | 214 | $294,604 |
| 2019 | 4,135 | 14 | 245 | $367,733 |
| 2018 | 2,496 | 2 | 236 | $143,740 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 3,283 | $502,619 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 14 | $1,032 |
| Service | 12 | $516 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 288 | $9 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 294 | $9 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 221 | $9 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 268 | $9 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 868 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 602 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 230 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 31 | $0 |
| Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use | 70 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,771 | $265,219 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 42 | $2,822 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $2,503 |
| Service | 49 | $2,108 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 247 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 167 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 76 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 171 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 217 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 145 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 63 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine and inactivated poliovirus vaccine (DTaP-IPV), when administered to children 4 through 6 years of age, for intramuscular use | 13 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,676 | $333,689 |
| Service | 30 | $1,291 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 356 | $9 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 409 | $9 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 309 | $9 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 343 | $9 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 278 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 143 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 158 | $0 |
| Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use | 71 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,235 | $279,665 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 66 | $6,826 |
| Service | 115 | $4,948 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 43 | $3,165 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 192 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 154 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 278 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 286 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 169 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 156 | $0 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 39 | $0 |
| Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use | 87 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 2,877 | $359,065 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 47 | $3,618 |
| Service | 73 | $3,141 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 42 | $1,910 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 108 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 91 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 176 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 199 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 137 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 161 | $0 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 14 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 2,437 | $141,201 |
| Service | 59 | $2,539 |
Money from drug and device companies
$28 in 2024
A payment is not proof that care is biased.
| bioMerieux | Biofire Respiratory Panel 2.1-Ez Eua, 30 Tests | $28 | 1 payment
|
See the published payment
| bioMerieux | Meals · 2024-11-06 | Biofire Respiratory Panel 2.1-Ez Eua, 30 Tests | $28 |
Professional record
- NPI
- 1457545832
- Licence
- CA A109208California A109208: Current · expires 2026-11-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080A0000X (2080A0000X)
- Mailing address
- Po Box 2626, Los Banos, CA, 93635
- NPI first listed
- 2007-08-29
- NPI last updated
- 2019-11-24
This is when the NPI record was last certified, not a medical board exam.